Canada In-Vitro Diagnostics Market is predicted to reach USD 6.51 Billion by 2030

According to the study by Next Move Strategy Consulting, the Canada In-Vitro Diagnostics Market size is predicted to reach USD 6.51 billion, at a CAGR of 5.7% by 2030.

Request a FREE Sample: https://www.nextmsc.com/canada-in-vitro-diagnostics-market/request-sample

Expansion in healthcare expenditure is significantly driving the in-vitro diagnostics market growth in the region. 

The expansion of an international molecular diagnostics group in the country, aimed at providing various molecular diagnostics services to the Canadian population, significantly contributes to the Canada of the in-vitro diagnostics market growth.

The promising players operating in the Canada in-vitro diagnostics industry include Roche Holding AG, Abbott Laboratories, Thermo Fisher Scientific Inc, Danaher Corporation, Becton, Dickinson and Company, Siemens Healthineers AG, bioMérieux SA, Sysmex Corporation, QIAGEN N.V., and Bio-Rad Laboratories, Inc., and others.